C

Cyclerion

25 employees

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical

Date founded

2019

Funding rounds raised

Total raised

$175M

from 7 investors over 7 rounds

C

Cyclerion raised $18M on June 4, 2021

Investors: Lincoln Park Capital, LLC, Slate Path Capital LP, The Invus Group and Polaris Partners

C

Cyclerion raised $24M on July 31, 2020

Investors: Slate Path Capital LP and Pappas Capital

C

Cyclerion raised $175M on April 2, 2019

Investors: Polaris Partners

FAQ